Antagonism of Δ9-THC induced behavioral effects by rimonabant: Time course studies in rats

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 133-138

  Järbe, Torbjörn U C ^a   Gifford, Roger S ^a   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

9 THC; Drug discrimination; Fixed ratio responding; Rat; Rimonabant; Time course

Indexed keywords

DRONABINOL; RIMONABANT; CANNABINOID 1 RECEPTOR; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG STABILITY; FOOD INTAKE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; ANIMAL; ANIMAL BEHAVIOR; DRUG INTERACTION; INVERSE AGONISM; LEARNING; PERCEPTIVE DISCRIMINATION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BEHAVIOR, ANIMAL; DISCRIMINATION (PSYCHOLOGY); DRUG INTERACTIONS; DRUG INVERSE AGONISM; GENERALIZATION (PSYCHOLOGY); MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 77957755694     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.006     Document Type: Article

References (26)

1. Baskfield C.Y., Martin B.R., Wiley J.L. Differential effects of delta-9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. J. Pharmacol. Exp. Ther. 2004, 309:86-91.
2. De Vry J., Jentzsch K.R. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm. Behav. Pharmacol. 2004, 15:13-20.
3. De Vry J., Schreiber R., Eckel G., Jentzsch K.R. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur. J. Pharmacol. 2004, 483:55-63.
4. Extance K., Goudie A.J. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology (Berl) 1981, 73:363-371.
5. Huestis M.A., Boyd S.J., Heishman S.J., Preston K.L., Bonnet D., Le Fur G., Gorelick D.A. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) 2007, 194:505-515.
6. Järbe, T.U.C., 1989. Discrimination learning with drug stimuli: methods and applications. In: Boulten, A.A., Baker, G.B., Greenshaw, A.J. (Eds.), Neuromethods: Vol. 13. Psychopharmacology. Humana Press, Clifton, N.J, pp. 513-563.
7. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology (Berl) 2001, 156:369-380.
8. Järbe T.U.C., Andrzejewski M.E., DiPatrizio N.V. Interactions between the CB1 receptor agonist delta-9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. Pharmacol. Biochem. Behav. 2002, 73:911-919.
9. Järbe T.U.C., DiPatrizio N.V., Li C., Makriyannis A. The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats. Pharmacol. Biochem. Behav. 2003, 75:809-821.
10. 9-THC or (R)-methanandamide (AM-356). Psychopharmacology (Berl) 2006, 188:315-323.
11. Järbe T.U.C., Liu Q., Makriyannis A. Antagonism of discriminative stimulus effects of delta-9-THC and (R)-methanandamide in rats. Psychopharmacology (Berl) 2006, 184:36-45.
12. Järbe T.U.C., LeMay B.J., Olszewska T., Vemuri V.K., Wood J.T., Makriyannis A. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats. Pharmacol. Biochem. Behav. 2008, 91:84-90.
13. Järbe T.U.C., Li C., Liu Q., Makriyannis A. Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog. Psychopharmacology (Berl) 2009, 203:229-239.
14. Järbe T.U.C., Li C., Vadivel S.K., Makriyannis A. Discriminative stimulus functions of methanandamide and Δ9-THC in rats: tests with aminoalkylindoles (WIN55, 212-2 and AM678) and ethanol. Psychopharmacology (Berl) 2010, 208:87-98.
15. Lamb R.J., Järbe T.U.C., Makriyannis A., Lin S., Goutopoulos A. Effects of Δ9-tetrahydrocannabinol, (R)-methanandamide, SR 141716, and d-amphetamine before and during daily Δ9-tetrahydrocannabinol dosing. Eur. J. Pharmacol. 2000, 398:251-258.
16. Le Foll B., Gorelick D.A., Goldberg S.R. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) 2009, 205:171-174.
17. Mansbach R.S., Rovetti C.C., Winston E.N., Lowe J.A. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) 1996, 124:315-322.
18. McLaughlin P.J., Winston K., Swezey L., Wisniecki A., Aberman J., Tardif D.J., Betz A.J., Ishiwari K., Makriyannis A., Salamone J.D. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav. Pharmacol. 2003, 14:583-588.
19. 9-tetrahydrocannabinol in C57BL/6J mice. Psychopharmacology (Berl) 2008, 198:487-495.
20. Perio A., Rinaldi-Carmona M., Maruani J., Barth F., Le Fur G., Soubrie P. Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav. Pharmacol. 1996, 7:65-71.
21. Salamone J.D., McLaughlin P.J., Sink K., Makriyannis A., Parker L.A. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiol. Behav. 2007, 91:383-388.
22. Sidman M. Tactics of Scientific Research-Evaluating Experimental Data in Psychology 1960, Basic Books, New York.
23. Solinas M., Panlilio L.V., Antoniou K., Pappas L.A., Goldberg S.R. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther. 2003, 306:93-102.
24. 9-THC by rimonabant: time-course studies in rats 2010, International Cannabinoid Research Society (ICRS), Burlington, VT.
25. Vann R.E., Warner J.A., Bushell K., Huffman J.W., Martin B.R., Wiley J.L. Discriminative stimulus properties of delta-9-tetrahydrocannabinol (THC) in C57Bl/6J mice. Eur. J. Pharmacol. 2009, 615:102-107.
26. Wiley J.L., Lowe J.A., Balster R.L., Martin B.R. Antagonism of the discriminative stimulus effects of delta-9-tetrahydrocannabinol in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 1995, 275:1-6.